Marc Massanari

1.2k total citations
43 papers, 926 citations indexed

About

Marc Massanari is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Marc Massanari has authored 43 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Immunology and Allergy. Recurrent topics in Marc Massanari's work include Asthma and respiratory diseases (30 papers), Allergic Rhinitis and Sensitization (16 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Marc Massanari is often cited by papers focused on Asthma and respiratory diseases (30 papers), Allergic Rhinitis and Sensitization (16 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Marc Massanari collaborates with scholars based in United States, Switzerland and United Kingdom. Marc Massanari's co-authors include Farid Kianifard, Robert K. Zeldin, William W. Busse, Gregory P. Geba, Pablo A. Jimenez, Leon Reinstein, Stephen T. Holgate, Nicola J. Smith, Thomas B. Casale and Harold S. Nelson and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Marc Massanari

42 papers receiving 891 citations

Peers

Marc Massanari
Patricia A. Loftus United States
Müjdat M. Başaran Türkiye
Philipp Deindl Germany
Marina Attanasi Italy
Recep Sancak Türkiye
Elisabeth H. Ference United States
J. R. M. Bateman United Kingdom
PJ Sterk Netherlands
Dan Atkins United States
Salvatore Fuschillo Italy
Patricia A. Loftus United States
Marc Massanari
Citations per year, relative to Marc Massanari Marc Massanari (= 1×) peers Patricia A. Loftus

Countries citing papers authored by Marc Massanari

Since Specialization
Citations

This map shows the geographic impact of Marc Massanari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Massanari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Massanari more than expected).

Fields of papers citing papers by Marc Massanari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Massanari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Massanari. The network helps show where Marc Massanari may publish in the future.

Co-authorship network of co-authors of Marc Massanari

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Massanari. A scholar is included among the top collaborators of Marc Massanari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Massanari. Marc Massanari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massanari, Marc, et al.. (2019). Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma. SHILAP Revista de lepidopterología. 1 indexed citations
2.
Brooks, Elizabeth, Marc Massanari, Nicola A. Hanania, & Daniel J. Weiner. (2019). <p>Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma</p>. ClinicoEconomics and Outcomes Research. Volume 11. 301–307. 15 indexed citations
3.
Brooks, Elizabeth & Marc Massanari. (2018). Cost-Effectiveness Analysis of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in the Management of Asthma.. PubMed. 27(7). 42–48. 12 indexed citations
4.
Hanania, Nicola A., Marc Massanari, & Neal Jain. (2018). Measurement of fractional exhaled nitric oxide in real-world clinical practice alters asthma treatment decisions. Annals of Allergy Asthma & Immunology. 120(4). 414–418.e1. 22 indexed citations
5.
Arnold, Renée J.G., et al.. (2018). Cost impact of monitoring exhaled nitric oxide in asthma management. Allergy and Asthma Proceedings. 39(5). 338–344. 7 indexed citations
6.
Massanari, Marc, et al.. (2017). Cost-Effectiveness of Using Fractional Exhaled Nitric Oxide in the Management of Asthma. CHEST Journal. 152(4). A20–A20. 1 indexed citations
7.
Karpel, Jill P., Marc Massanari, Gregory P. Geba, et al.. (2010). Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthma. Annals of Allergy Asthma & Immunology. 105(6). 465–470. 17 indexed citations
8.
Massanari, Marc, Harold S. Nelson, Thomas B. Casale, et al.. (2010). Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. Journal of Allergy and Clinical Immunology. 125(2). 383–389. 166 indexed citations
9.
Massanari, Marc, S.T. Holgate, William W. Busse, et al.. (2009). Effect of omalizumab on peripheral blood eosinophilia in allergic asthma. Respiratory Medicine. 104(2). 188–196. 92 indexed citations
10.
Haselkorn, Tmirah, Robert S. Zeiger, Bradley E. Chipps, et al.. (2009). Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. Journal of Allergy and Clinical Immunology. 124(5). 921–927. 90 indexed citations
11.
Sorkness, Christine A., et al.. (2009). Eligibility for Omalizumab Dosing in Children and Young Adults Based on IgE and Body Weight. Journal of Allergy and Clinical Immunology. 123(2). S80–S80. 2 indexed citations
12.
Holgate, Stephen T., Nicola J. Smith, Marc Massanari, & Pablo A. Jimenez. (2009). Effects of omalizumab on markers of inflammation in patients with allergic asthma. Allergy. 64(12). 1728–1736. 105 indexed citations
13.
Marcus, Philip, Renée J.G. Arnold, Sean Ekins, et al.. (2008). A retrospective randomized study of asthma control in the US: results of the CHARIOT study. Current Medical Research and Opinion. 24(12). 3443–3452. 27 indexed citations
14.
Busse, William W., Marc Massanari, Farid Kianifard, & Gregory P. Geba. (2007). Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis. Current Medical Research and Opinion. 23(10). 2379–2386. 40 indexed citations
15.
Milgrom, Henry, Marc Massanari, Robert Maykut, et al.. (2007). OMALIZUMAB IMPROVES TREATMENT EFFECTIVENESS OF CHILDREN AND ADOLESCENTS WITH MODERATE-SEVERE PERSISTENT IGE-MEDIATED ASTHMA AND REDUCES SCHOOL ABSENTEEISM. CHEST Journal. 132(4). 483B–483B. 1 indexed citations
16.
Massanari, Marc, Robert Maykut, Robert K. Zeldin, Farid Kianifard, & Gregory P. Geba. (2006). ADDITION OF OMALIZUMAB IMPROVES LUNG FUNCTION AND TREATMENT EFFECTIVENESS IN PATIENTS WITH MODERATE-SEVERE PERSISTENT ALLERGIC ASTHMA INADEQUATELY CONTROLLED WITH INHALED STEROIDS AND LONG-ACTING BETA-AGONISTS. CHEST Journal. 130(4). 109S–109S. 2 indexed citations
17.
Maykut, Robert, Marc Massanari, Farid Kianifard, et al.. (2005). OMALIZUMAB IMPROVES SYMPTOMS AND REDUCES RESCUE BETA-AGONIST USE IN OLDER PATIENTS WITH UNCONTROLLED ASTHMA. CHEST Journal. 128(4). 243S–243S. 1 indexed citations
18.
Kinzie, Joseph L., Paul H. Naylor, Rene Peleman, et al.. (2001). African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians. Journal of Viral Hepatitis. 8(4). 264–269. 64 indexed citations
19.
Schurman, Scott J., et al.. (1998). Tubulointerstitial Nephritis Induced by the Leukotriene Receptor Antagonist Pranlukast. CHEST Journal. 114(4). 1220–1223. 13 indexed citations
20.
Riney, Sherry J., Michael Grimes, K Khalifé, L H Warbasse, & Marc Massanari. (1991). Diarrhea associated with disinfection of sigmoidoscopes. American Journal of Infection Control. 19(2). 109–109. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia A. Loftus Breakdown of academic impact, for papers by Müjdat M. Başaran Breakdown of academic impact, for papers by Philipp Deindl Breakdown of academic impact, for papers by Marina Attanasi Breakdown of academic impact, for papers by Recep Sancak Breakdown of academic impact, for papers by Elisabeth H. Ference Breakdown of academic impact, for papers by J. R. M. Bateman Breakdown of academic impact, for papers by PJ Sterk Breakdown of academic impact, for papers by Dan Atkins Breakdown of academic impact, for papers by Salvatore Fuschillo
Rankless by CCL
2026